Table 2:
Distribution of 24-h UOx overall and among patients with a malabsorptive condition.
| All patients (N = 447 958) | Patients with a malabsorptive condition (N = 12 522) | |
|---|---|---|
| Urine oxalate (mg/24 h), n (%) | ||
| <20 | 35 246 (7.9) | 991 (7.9) |
| 20–29 | 136 608 (30.5) | 3320 (26.5) |
| 30–39 | 137 148 (30.6) | 3265 (26.1) |
| 40–44 | 45 040 (10.1) | 1102 (8.8) |
| 45–49 | 31 216 (7.0) | 902 (7.2) |
| 50–59 | 33 868 (7.6) | 1154 (9.2) |
| 60–69 | 14 766 (3.3) | 684 (5.5) |
| 70–79 | 6863 (1.5) | 437 (3.5) |
| 80+ | 7203 (1.6) | 667 (5.3) |
| Urine oxalate 40+ mg/24 h, n (%) | 138 956 (31.0) | 4946 (39.5) |
| Urine oxalate 45+ mg/24 h, n (%) | 93 916 (21.0) | 3844 (30.7) |
| Urine oxalate (mg/24 h) | ||
| Mean (SD) | 36.1 (14.6) | 40.5 (19.5) |
| Min, max | 11.0, 117.8 | 11.0, 117.5 |
| Median (Q1–Q3) | 33.4 (26.2–42.8) | 35.4 (27.0–48.7) |
All values are from the index urine test.